Cancer Drug Gleevec Linked to Muscle Damage, Data Published in New England Journal of Medicine

HealthDay News -- French doctors have reported a possible new side effect associated with the cancer drug Gleevec (imatinib), widely used for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors.

MORE ON THIS TOPIC